Skip to main content

Animations

MJFF Publications

2021 - 2030 of 8826 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2021
  • 2022
  • 2021
  • 2021
  • 2020
  • 2021
  • 2021
  • Quantum diamond biomarker detection
    2022
    Summary Details
    RESTRICTED
    Title: Quantum diamond biomarker detection
    Journal Name: PhotonicsViews
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/phvs.202270107
    Citation Count: 1
  • Summary Details
    OPEN
    Title: ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 2022
    Journal Name: Pharmacoepidemiology and Drug Safety
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/pds.5518
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Spatially informed Bayesian neural network for neurodegenerative diseases classification
    Journal Name: Statistics in Medicine
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/sim.9604
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Objective screening for olfactory and gustatory dysfunction during the COVID‐19 pandemic: A prospective study in healthcare workers using self‐administered testing
    Journal Name: World Journal of Otorhinolaryngology - Head and Neck Surgery
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.wjorl.2021.02.001
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Symposia
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ene.15461
    Citation Count: 3
  • Summary Details
    OPEN
    Title: An efficient and scalable synthesis of thiazolo ring fused 2-pyridones using flow chemistry
    Journal Name: Arkivoc
    Publisher: ARKAT USA, Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.24820/ark.5550190.p011.445
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis
    Journal Name: Journal of Managed Care & Specialty Pharmacy
    Publisher: Academy of Managed Care Pharmacy
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.18553/jmcp.2021.27.6.785
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition
    Journal Name: Molecular Cancer Therapeutics
    Publisher: American Association for Cancer Research (AACR)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1158/1535-7163.mct-20-0259
    Citation Count: 14
  • Summary Details
    OPEN
    Title: CD4 + T cells contribute to neurodegeneration in Lewy body dementia
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.abf7266
    Citation Count: 215
  • Summary Details
    OPEN
    Title: PARIS farnesylation prevents neurodegeneration in models of Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aax8891
    Citation Count: 63
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.